Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis.

Rizk D, Jurkovitz C, Veledar E, Bagby S, Baumgarten DA, Rahbari-Oskoui F, Steinman T, Chapman AB.

Clin J Am Soc Nephrol. 2009 Mar;4(3):560-6. doi: 10.2215/CJN.02410508. Epub 2009 Mar 4.

2.

Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.

Miskulin DC, Abebe KZ, Chapman AB, Perrone RD, Steinman TI, Torres VE, Bae KT, Braun W, Winklhofer FT, Hogan MC, Rahbari-Oskoui F, Moore CG, Flessner MF, Schrier RW; HALT-PKD Study.

Am J Kidney Dis. 2014 Feb;63(2):214-26. doi: 10.1053/j.ajkd.2013.08.017. Epub 2013 Nov 1.

3.

Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study.

Suwabe T, Ubara Y, Mise K, Kawada M, Hamanoue S, Sumida K, Hayami N, Hoshino J, Hiramatsu R, Yamanouchi M, Hasegawa E, Sawa N, Takaichi K.

BMC Nephrol. 2013 Aug 27;14:179. doi: 10.1186/1471-2369-14-179.

4.

ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.

Reule S, Sexton DJ, Solid CA, Chen SC, Collins AJ, Foley RN.

Am J Kidney Dis. 2014 Oct;64(4):592-9. doi: 10.1053/j.ajkd.2014.05.020. Epub 2014 Aug 16.

5.

The relationship between renal volume and renal function in autosomal dominant polycystic kidney disease.

Tokiwa S, Muto S, China T, Horie S.

Clin Exp Nephrol. 2011 Aug;15(4):539-45. doi: 10.1007/s10157-011-0428-y. Epub 2011 Mar 24.

PMID:
21431900
6.

Are preoperative health-related quality of life scores predictive of clinical outcomes after lumbar fusion?

Carreon LY, Glassman SD, Djurasovic M, Dimar JR, Johnson JR, Puno RM, Campbell MJ.

Spine (Phila Pa 1976). 2009 Apr 1;34(7):725-30. doi: 10.1097/BRS.0b013e318198cae4.

PMID:
19333106
7.

Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.

Spithoven EM, Meijer E, Boertien WE, Sinkeler SJ, Tent H, de Jong PE, Navis G, Gansevoort RT.

Am J Kidney Dis. 2013 Sep;62(3):531-40. doi: 10.1053/j.ajkd.2013.03.030. Epub 2013 May 25.

PMID:
23714171
8.

Baseline characteristics influencing quality of life in women undergoing gynecologic oncology surgery.

Gil KM, Gibbons HE, Jenison EL, Hopkins MP, von Gruenigen VE.

Health Qual Life Outcomes. 2007 May 17;5:25.

9.

Laparoscopic cyst decortication in autosomal dominant polycystic kidney disease: impact on pain, hypertension, and renal function.

Lee DI, Andreoni CR, Rehman J, Landman J, Ragab M, Yan Y, Chen C, Shindel A, Middleton W, Shalhav A, McDougall EM, Clayman RV.

J Endourol. 2003 Aug;17(6):345-54.

PMID:
12965058
10.

Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.

Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, Kenney PJ, King BF Jr, Glockner JF, Wetzel LH, Brummer ME, O'Neill WC, Robbin ML, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.

Kidney Int. 2003 Sep;64(3):1035-45.

PMID:
12911554
11.

Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease.

Meijer E, Drenth JP, d'Agnolo H, Casteleijn NF, de Fijter JW, Gevers TJ, Kappert P, Peters DJ, Salih M, Soonawala D, Spithoven EM, Torres VE, Visser FW, Wetzels JF, Zietse R, Gansevoort RT; DIPAK Consortium.

Am J Kidney Dis. 2014 Mar;63(3):446-55. doi: 10.1053/j.ajkd.2013.10.011. Epub 2013 Dec 15.

12.

Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.

Torres VE, Grantham JJ, Chapman AB, Mrug M, Bae KT, King BF Jr, Wetzel LH, Martin D, Lockhart ME, Bennett WM, Moxey-Mims M, Abebe KZ, Lin Y, Bost JE; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Clin J Am Soc Nephrol. 2011 Mar;6(3):640-7. doi: 10.2215/CJN.03250410. Epub 2010 Nov 18.

13.

"An evil heritage": interview study of pain and autosomal dominant polycystic kidney disease.

Heiwe S, Bjuke M.

Pain Manag Nurs. 2009 Sep;10(3):134-41. doi: 10.1016/j.pmn.2009.03.002.

PMID:
19706350
14.

Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey.

Salaffi F, Sarzi-Puttini P, Girolimetti R, Atzeni F, Gasparini S, Grassi W.

Clin Exp Rheumatol. 2009 Sep-Oct;27(5 Suppl 56):S67-74.

PMID:
20074443
15.

Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney disease.

Chen D, Ma Y, Wang X, Yu S, Li L, Dai B, Mao Z, Sun L, Xu C, Rong S, Tang M, Zhao H, Liu H, Serra AL, Graf N, Liu S, Wüthrich RP, Mei C.

PLoS One. 2014 Mar 20;9(3):e92232. doi: 10.1371/journal.pone.0092232. eCollection 2014.

16.

Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease.

Choukroun G, Itakura Y, Albouze G, Christophe JL, Man NK, Grünfeld JP, Jungers P.

J Am Soc Nephrol. 1995 Dec;6(6):1634-42.

17.

Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine.

Gronwald W, Klein MS, Zeltner R, Schulze BD, Reinhold SW, Deutschmann M, Immervoll AK, Böger CA, Banas B, Eckardt KU, Oefner PJ.

Kidney Int. 2011 Jun;79(11):1244-53. doi: 10.1038/ki.2011.30. Epub 2011 Mar 9.

PMID:
21389975
18.

Building a network of ADPKD reference centres across Europe: the EuroCYST initiative.

Petzold K, Gansevoort RT, Ong AC, Devuyst O, Rotar L, Eckardt KU, Köttgen A, Pirson Y, Remuzzi G, Sandford R, Tesar V, Ecder T, Chaveau D, Torra R, Budde K, Le Meur Y, Wüthrich RP, Serra AL.

Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv26-32. doi: 10.1093/ndt/gfu091. Erratum in: Nephrol Dial Transplant. 2014 Dec;29(12):2353.

PMID:
25165183
19.

Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease.

Heffernan KS, Kuvin JT, Sarnak MJ, Perrone RD, Miskulin DC, Rudym D, Chandra P, Karas RH, Menon V.

Nephrol Dial Transplant. 2011 Aug;26(8):2515-21. doi: 10.1093/ndt/gfq806. Epub 2011 Feb 3.

20.

Exercise capacity in polycystic kidney disease.

Reinecke NL, Cunha TM, Heilberg IP, Higa EM, Nishiura JL, Neder JA, Almeida WS, Schor N.

Am J Kidney Dis. 2014 Aug;64(2):239-46. doi: 10.1053/j.ajkd.2014.03.014. Epub 2014 Apr 29.

PMID:
24787761
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk